Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-260,953
Closed -$35.5M 37
2025
Q1
$35.5M Sell
260,953
-157,027
-38% -$24.1M 3.13% 18
2024
Q4
$60.1M Buy
417,980
+5,543
+1% +$727K 4.53% 11
2024
Q3
$49.4M Sell
412,437
-178,134
-30% -$19.3M 3.66% 14
2024
Q2
$64.2M Buy
590,571
+307,654
+109% +$37.3M 4.62% 8
2024
Q1
$37.9M Buy
282,917
+57,204
+25% +$7.68M 4.27% 10
2023
Q4
$28.8M Buy
+225,713
New +$28.7M 3.46% 16

Other funds holding JBL

M.D. Sass LLC's JBL Position: Q2 2025 in Review

M.D. Sass LLC sold out of Jabil (JBL) in Q2 2025, closing a stake of 260,953 shares — an estimated $35.5M sold.

M.D. Sass LLC first reported a position in JBL in Q4 2023 and held it in 6 quarters. The position peaked at $64.2M in Q2 2024. 875 funds tracked by Wall St. Rank hold JBL as of Q2 2025.

  • M.D. Sass LLC reported no remaining Jabil position as of Q2 2025 after selling out during the quarter.
  • M.D. Sass LLC sold 260,953 Jabil shares in Q2 2025, an estimated $35.5M.
  • M.D. Sass LLC first reported a position in Jabil in Q4 2023 and held it in 6 quarters.
  • M.D. Sass LLC's Jabil position peaked at $64.2M in Q2 2024.
  • 875 funds tracked by Wall St. Rank held Jabil as of Q2 2025.

Based on M.D. Sass LLC's 13F filing for Q2 2025, filed 13 Aug 2025.